List of Tables
Table 1. Global Gene Therapy Market Size Growth Rate (CAGR) by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Global Gene Therapy Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 3. Global Gene Therapy Market Size by Region (US$ Million): 2024 VS 2031
Table 4. Global Gene Therapy Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global Gene Therapy Revenue Forecast by Region (2026-2031) & (US$ Million)
Table 6. Global Gene Therapy Revenue by Type (2020-2025) & (US$ Million)
Table 7. Global Gene Therapy Revenue Forecast by Type (2026-2031) & (US$ Million)
Table 8. Global Gene Therapy Revenue by Application (2020-2025) & (US$ Million)
Table 9. Global Gene Therapy Revenue Forecast by Application (2026-2031) & (US$ Million)
Table 10. Gene Therapy Revenue by Company (2020-2025) & (US$ Million)
Table 11. Gene Therapy Revenue Share by Company (2020-2025)
Table 12. Ranking of Global Top Gene Therapy Players by Revenue (US$ Million) in 2024
Table 13. Global Gene Therapy Companies Market Concentration Ratio (CR5 and HHI) & (2020-2025)
Table 14. Global Gene Therapy by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gene Therapy as of 2024)
Table 15. Global Gene Therapy Companies Headquarters
Table 16. Date of International Companies Enter into Gene Therapy Market
Table 17. Global Gene Therapy Companies Product & Service
Table 18. Global Gene Therapy Mergers & Acquisitions, Expansion Plans
Table 19. Biogen Corporation Information
Table 20. Biogen Description and Business Overview
Table 21. Biogen Gene Therapy Product
Table 22. Biogen Gene Therapy Revenue (US$ Million) and Gross Margin (2020-2025)
Table 23. Biogen Revenue Proportion of Gene Therapy by Product in 2024
Table 24. Biogen Revenue Proportion of Gene Therapy by Application in 2024
Table 25. Biogen Revenue Proportion of Gene Therapy by Geographic Area in 2024
Table 26. Biogen Recent Developments
Table 27. Novartis Corporation Information
Table 28. Novartis Description and Business Overview
Table 29. Novartis Gene Therapy Product
Table 30. Novartis Gene Therapy Revenue (US$ Million) and Gross Margin (2020-2025)
Table 31. Novartis Revenue Proportion of Gene Therapy by Product in 2024
Table 32. Novartis Revenue Proportion of Gene Therapy by Application in 2024
Table 33. Novartis Revenue Proportion of Gene Therapy by Geographic Area in 2024
Table 34. Novartis Recent Developments
Table 35. Gilead Sciences Corporation Information
Table 36. Gilead Sciences Description and Business Overview
Table 37. Gilead Sciences Gene Therapy Product
Table 38. Gilead Sciences Gene Therapy Revenue (US$ Million) and Gross Margin (2020-2025)
Table 39. Gilead Sciences Revenue Proportion of Gene Therapy by Product in 2024
Table 40. Gilead Sciences Revenue Proportion of Gene Therapy by Application in 2024
Table 41. Gilead Sciences Revenue Proportion of Gene Therapy by Geographic Area in 2024
Table 42. Gilead Sciences Recent Developments
Table 43. Sarepta Therapeutics Corporation Information
Table 44. Sarepta Therapeutics Description and Business Overview
Table 45. Sarepta Therapeutics Gene Therapy Product
Table 46. Sarepta Therapeutics Gene Therapy Revenue (US$ Million) and Gross Margin (2020-2025)
Table 47. Sarepta Therapeutics Revenue Proportion of Gene Therapy by Product in 2024
Table 48. Sarepta Therapeutics Revenue Proportion of Gene Therapy by Application in 2024
Table 49. Sarepta Therapeutics Revenue Proportion of Gene Therapy by Geographic Area in 2024
Table 50. Sarepta Therapeutics Recent Developments
Table 51. Alnylam Pharmaceuticals Corporation Information
Table 52. Alnylam Pharmaceuticals Description and Business Overview
Table 53. Alnylam Pharmaceuticals Gene Therapy Product
Table 54. Alnylam Pharmaceuticals Gene Therapy Revenue (US$ Million) and Gross Margin (2020-2025)
Table 55. Alnylam Pharmaceuticals Revenue Proportion of Gene Therapy by Product in 2024
Table 56. Alnylam Pharmaceuticals Revenue Proportion of Gene Therapy by Application in 2024
Table 57. Alnylam Pharmaceuticals Revenue Proportion of Gene Therapy by Geographic Area in 2024
Table 58. Alnylam Pharmaceuticals Recent Developments
Table 59. Amgen Corporation Information
Table 60. Amgen Description and Business Overview
Table 61. Amgen Gene Therapy Product
Table 62. Amgen Gene Therapy Revenue (US$ Million) and Gross Margin (2020-2025)
Table 63. Amgen Revenue Proportion of Gene Therapy by Product in 2024
Table 64. Amgen Revenue Proportion of Gene Therapy by Application in 2024
Table 65. Amgen Revenue Proportion of Gene Therapy by Geographic Area in 2024
Table 66. Amgen Recent Developments
Table 67. Spark Therapeutics Corporation Information
Table 68. Spark Therapeutics Description and Business Overview
Table 69. Spark Therapeutics Gene Therapy Product
Table 70. Spark Therapeutics Gene Therapy Revenue (US$ Million) and Gross Margin (2020-2025)
Table 71. Spark Therapeutics Revenue Proportion of Gene Therapy by Product in 2024
Table 72. Spark Therapeutics Revenue Proportion of Gene Therapy by Application in 2024
Table 73. Spark Therapeutics Revenue Proportion of Gene Therapy by Geographic Area in 2024
Table 74. Spark Therapeutics Recent Developments
Table 75. Akcea Therapeutics Corporation Information
Table 76. Akcea Therapeutics Description and Business Overview
Table 77. Akcea Therapeutics Gene Therapy Product
Table 78. Akcea Therapeutics Gene Therapy Revenue (US$ Million) and Gross Margin (2020-2025)
Table 79. Akcea Therapeutics Revenue Proportion of Gene Therapy by Product in 2024
Table 80. Akcea Therapeutics Revenue Proportion of Gene Therapy by Application in 2024
Table 81. Akcea Therapeutics Revenue Proportion of Gene Therapy by Geographic Area in 2024
Table 82. Akcea Therapeutics Recent Developments
Table 83. bluebird bio Corporation Information
Table 84. bluebird bio Description and Business Overview
Table 85. bluebird bio Gene Therapy Product
Table 86. bluebird bio Gene Therapy Revenue (US$ Million) and Gross Margin (2020-2025)
Table 87. bluebird bio Revenue Proportion of Gene Therapy by Product in 2024
Table 88. bluebird bio Revenue Proportion of Gene Therapy by Application in 2024
Table 89. bluebird bio Revenue Proportion of Gene Therapy by Geographic Area in 2024
Table 90. bluebird bio Recent Developments
Table 91. Sunway Biotech Corporation Information
Table 92. Sunway Biotech Description and Business Overview
Table 93. Sunway Biotech Gene Therapy Product
Table 94. Sunway Biotech Gene Therapy Revenue (US$ Million) and Gross Margin (2020-2025)
Table 95. Sunway Biotech Revenue Proportion of Gene Therapy by Product in 2024
Table 96. Sunway Biotech Revenue Proportion of Gene Therapy by Application in 2024
Table 97. Sunway Biotech Revenue Proportion of Gene Therapy by Geographic Area in 2024
Table 98. Sunway Biotech Recent Developments
Table 99. SIBIONO Corporation Information
Table 100. SIBIONO Description and Business Overview
Table 101. SIBIONO Gene Therapy Product
Table 102. SIBIONO Gene Therapy Revenue (US$ Million) and Gross Margin (2020-2025)
Table 103. SIBIONO Revenue Proportion of Gene Therapy by Product in 2024
Table 104. SIBIONO Revenue Proportion of Gene Therapy by Application in 2024
Table 105. SIBIONO Revenue Proportion of Gene Therapy by Geographic Area in 2024
Table 106. SIBIONO Recent Developments
Table 107. AnGes Corporation Information
Table 108. AnGes Description and Business Overview
Table 109. AnGes Gene Therapy Product
Table 110. AnGes Gene Therapy Revenue (US$ Million) and Gross Margin (2020-2025)
Table 111. AnGes Revenue Proportion of Gene Therapy by Product in 2024
Table 112. AnGes Revenue Proportion of Gene Therapy by Application in 2024
Table 113. AnGes Revenue Proportion of Gene Therapy by Geographic Area in 2024
Table 114. AnGes Recent Developments
Table 115. Orchard Therapeutics Corporation Information
Table 116. Orchard Therapeutics Description and Business Overview
Table 117. Orchard Therapeutics Gene Therapy Product
Table 118. Orchard Therapeutics Gene Therapy Revenue (US$ Million) and Gross Margin (2020-2025)
Table 119. Orchard Therapeutics Revenue Proportion of Gene Therapy by Product in 2024
Table 120. Orchard Therapeutics Revenue Proportion of Gene Therapy by Application in 2024
Table 121. Orchard Therapeutics Revenue Proportion of Gene Therapy by Geographic Area in 2024
Table 122. Orchard Therapeutics Recent Developments
Table 123. Human Stem Cells Institute Corporation Information
Table 124. Human Stem Cells Institute Description and Business Overview
Table 125. Human Stem Cells Institute Gene Therapy Product
Table 126. Human Stem Cells Institute Gene Therapy Revenue (US$ Million) and Gross Margin (2020-2025)
Table 127. Human Stem Cells Institute Revenue Proportion of Gene Therapy by Product in 2024
Table 128. Human Stem Cells Institute Revenue Proportion of Gene Therapy by Application in 2024
Table 129. Human Stem Cells Institute Revenue Proportion of Gene Therapy by Geographic Area in 2024
Table 130. Human Stem Cells Institute Recent Developments
Table 131. North America Gene Therapy Revenue by Country (2020-2025) & (US$ Million)
Table 132. North America Gene Therapy Revenue by Country (2026-2031) & (US$ Million)
Table 133. North America Gene Therapy Revenue by Type (2020-2025) & (US$ Million)
Table 134. North America Gene Therapy Revenue by Application (2020-2025) & (US$ Million)
Table 135. Asia-Pacific Gene Therapy Revenue by Region (2020-2025) & (US$ Million)
Table 136. Asia-Pacific Gene Therapy Revenue by Region (2026-2031) & (US$ Million)
Table 137. Asia-Pacific Gene Therapy Revenue by Type (2020-2025) & (US$ Million)
Table 138. Asia-Pacific Gene Therapy Revenue by Application (2020-2025) & (US$ Million)
Table 139. Europe Gene Therapy Revenue by Country (2020-2025) & (US$ Million)
Table 140. Europe Gene Therapy Revenue by Country (2026-2031) & (US$ Million)
Table 141. Europe Gene Therapy Revenue by Type (2020-2025) & (US$ Million)
Table 142. Europe Gene Therapy Revenue by Application (2020-2025) & (US$ Million)
Table 143. Latin America Gene Therapy Revenue by Country (2020-2025) & (US$ Million)
Table 144. Latin America Gene Therapy Revenue by Country (2026-2031) & (US$ Million)
Table 145. Latin America Gene Therapy Revenue by Type (2020-2025) & (US$ Million)
Table 146. Latin America Gene Therapy Revenue by Application (2020-2025) & (US$ Million)
Table 147. Middle East and Africa Gene Therapy Revenue by Country (2020-2025) & (US$ Million)
Table 148. Middle East and Africa Gene Therapy Revenue by Country (2026-2031) & (US$ Million)
Table 149. Middle East and Africa Gene Therapy Revenue by Type (2020-2025) & (US$ Million)
Table 150. Middle East and Africa Gene Therapy Revenue by Application (2020-2025) & (US$ Million)
Table 151. Gene Therapy Key Raw Materials, Industry Status and Trend
Table 152. Gene Therapy Key Raw Materials and Upstream Suppliers
Table 153. Gene Therapy Clients Status and Trend
Table 154. Gene Therapy Typical Clients
Table 155. Gene Therapy Distributors
Table 156. Gene Therapy Market Trends
Table 157. Gene Therapy Market Drivers
Table 158. Gene Therapy Market Challenges
Table 159. Gene Therapy Market Restraints
Table 160. Research Programs/Design for This Report
Table 161. Key Data Information from Secondary Sources
Table 162. Key Data Information from Primary Sources
List of Figures
Figure 1. Gene Therapy Product Picture
Figure 2. Global Gene Therapy Market Size by Type (US$ Million): 2020 VS 2024 VS 2031
Figure 3. Global Gene Therapy Revenue Market Share by Type in 2024 & 2031
Figure 4. Viral Gene Therapy Product Picture
Figure 5. Non-Viral Gene Therapy Product Picture
Figure 6. Global Gene Therapy Market Size by Application (US$ Million): 2020 VS 2024 VS 2031
Figure 7. Global Gene Therapy Revenue Market Share by Application in 2024 & 2031
Figure 8. Neurological Diseases
Figure 9. Cancer
Figure 10. Other
Figure 11. Gene Therapy Report Years Considered
Figure 12. Global Gene Therapy Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 13. Global Gene Therapy Market Size (2020-2031) & (US$ Million)
Figure 14. Global Gene Therapy Market Size Market Share by Region: 2024 Versus 2031
Figure 15. Global Gene Therapy Revenue Market Share by Region (2020-2031)
Figure 16. Global Gene Therapy Revenue Market Share Forecast by Type (2020-2031)
Figure 17. Global Gene Therapy Revenue Market Share Forecast by Application (2020-2031)
Figure 18. Viral Gene Therapy of Gene Therapy Revenue Market Share by Application, 2024 VS 2031
Figure 19. Non-Viral Gene Therapy of Gene Therapy Revenue Market Share by Application, 2024 VS 2031
Figure 20. Gene Therapy Revenue Share by Company (2024)
Figure 21. Gene Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 22. Viral Gene Therapy Revenue Proportion by Company in 2024
Figure 23. Non-Viral Gene Therapy Revenue Proportion by Company in 2024
Figure 24. North America Gene Therapy Revenue 2020-2031 (US$ Million)
Figure 25. North America Gene Therapy Revenue Market Share by Type (2020-2025)
Figure 26. North America Gene Therapy Revenue Market Share by Application (2020-2025)
Figure 27. Asia-Pacific Gene Therapy Revenue 2020-2031 (US$ Million)
Figure 28. Asia-Pacific Gene Therapy Revenue Market Share by Region (2020-2031)
Figure 29. Asia-Pacific Gene Therapy Revenue Market Share by Type (2020-2025)
Figure 30. Asia-Pacific Gene Therapy Revenue Market Share by Application (2020-2025)
Figure 31. Europe Gene Therapy Revenue Growth Rate 2020-2031 (US$ Million)
Figure 32. Europe Gene Therapy Revenue Market Share by Country (2020-2031)
Figure 33. Europe Gene Therapy Revenue Market Share by Type (2020-2025)
Figure 34. Europe Gene Therapy Revenue Market Share by Application (2020-2025)
Figure 35. Latin America Gene Therapy Revenue Growth Rate 2020-2031 (US$ Million)
Figure 36. Latin America Gene Therapy Revenue Market Share by Country (2020-2031)
Figure 37. Latin America Gene Therapy Revenue Market Share by Type (2020-2025)
Figure 38. Latin America Gene Therapy Revenue Market Share by Application (2020-2025)
Figure 39. Middle East and Africa Gene Therapy Revenue Growth Rate 2020-2031 (US$ Million)
Figure 40. Middle East and Africa Gene Therapy Revenue Market Share by Country (2020-2031)
Figure 41. Middle East and Africa Gene Therapy Revenue Market Share by Type (2020-2025)
Figure 42. Middle East and Africa Gene Therapy Revenue Market Share by Application (2020-2025)
Figure 43. Gene Therapy Supply Chain (Upstream and Downstream Market)
Figure 44. Global Production Market Share of Gene Therapy Raw Materials by Region in 2024
Figure 45. Gene Therapy Distribution Channels
Figure 46. Global Gene Therapy Percentage 2020-2031: Indirect Sales VS Direct Sales
Figure 47. Global Gene Therapy Percentage 2020-2031: Online Sales VS Offline Sales
Figure 48. Bottom-up and Top-down Approaches for This Report
Figure 49. Data Triangulation
Figure 50. Key Executives Interviewed
